Use of the human tumor stem cell assay (HTSCA) to prospectively select patients for phase I and II clinical trials of bisantrene (BIS)

David S Alberts, C. Mackel, S. E. Salmon

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)305
Number of pages1
JournalStem Cells
Volume1
Issue number4-5
StatePublished - 1981

Fingerprint

bisantrene
Tumor Stem Cell Assay
Phase II Clinical Trials
Clinical Trials, Phase I

ASJC Scopus subject areas

  • Cell Biology

Cite this

Use of the human tumor stem cell assay (HTSCA) to prospectively select patients for phase I and II clinical trials of bisantrene (BIS). / Alberts, David S; Mackel, C.; Salmon, S. E.

In: Stem Cells, Vol. 1, No. 4-5, 1981, p. 305.

Research output: Contribution to journalArticle

@article{774360ac61404cb9917e8a06fd061ba2,
title = "Use of the human tumor stem cell assay (HTSCA) to prospectively select patients for phase I and II clinical trials of bisantrene (BIS)",
author = "Alberts, {David S} and C. Mackel and Salmon, {S. E.}",
year = "1981",
language = "English (US)",
volume = "1",
pages = "305",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "4-5",

}

TY - JOUR

T1 - Use of the human tumor stem cell assay (HTSCA) to prospectively select patients for phase I and II clinical trials of bisantrene (BIS)

AU - Alberts, David S

AU - Mackel, C.

AU - Salmon, S. E.

PY - 1981

Y1 - 1981

UR - http://www.scopus.com/inward/record.url?scp=0019757409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019757409&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 305

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 4-5

ER -